Last update 25 Nov 2024
QR-12000
Last update 25 Nov 2024
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms QR 12000, QR12000 |
Target |
Mechanism AT2R antagonists(Angiotensin II receptor type 2 antagonists), enkephalinase inhibitors(Neprilysin inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 3 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
5
Clinical Trials associated with QR-12000OR12000复方片治疗中、重度原发性高血压患者的有效性和安全性的多中心、随机、双盲、阳性对照和平行组设计的 II 期临床研究
[Translation] A multicenter, randomized, double-blind, positive-controlled, parallel-group Phase II clinical study on the efficacy and safety of OR12000 compound tablets in the treatment of patients with moderate to severe essential hypertension
一项在中国健康成年受试者中评估进食对QR12000复方片生物利用度影响的单次给药、随机、两周期交叉研究
[Translation] A single-dose, randomized, two-period crossover study to evaluate the effect of food intake on the bioavailability of QR12000 compound tablets in healthy Chinese adult subjects
健康志愿者单多次口服QR12000 复方片的安全性、耐受性和药代动力学研究 （单中心、随机、双盲、安慰剂对照）
[Translation] Safety, tolerability and pharmacokinetics of single and multiple oral administration of QR12000 compound tablets in healthy volunteers (single-center, randomized, double-blind, placebo-controlled)
100 Clinical Results associated with QR-12000
Login to view more data
100 Translational Medicine associated with QR-12000
Login to view more data
100 Patents (Medical) associated with QR-12000
Login to view more data
100 Deals associated with QR-12000
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Essential Hypertension | Phase 3 | CN | 22 Nov 2024 | |
| Heart Failure | Phase 2 | CN | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free